There are 268 results
Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, will present two poster presentations of pivotal research abstracts at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting. This research delivers advanced intelligence to accelerate oncology trials by optimizing patient-centric breast cancer protocols and definitively validating tocilizumab’s efficacy for CAR T–induced Cytokine Release Syndrome (CRS).

Press Release

May 29, 2026

Worldwide Clinical Trials and Medidata Announce Strategic Partnership to Embed Medidata AI Across the Full Trial Lifecycle, Bolstering Study Execution and Delivery Excellence

Worldwide Clinical Trials, Inc., a global contract research organization (CRO), and Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, announced a strategic evolution of their partnership to enable a more connected and insight-driven research model for smarter clinical trials.

Press Release

April 23, 2026

AI Driven Innovation

Explore how 3D UNIVERSES, powered by industrial AI, help you predict outcomes, reduce risks and deliver higher-quality therapies faster than ever before.

Article

Project Members

The Living Heart Project connects medical and biomedical experts to bring the vision of virtual twins capable of safely testing new innovations and guiding precise treatments to reality.

Article

Medidata Expands Partnership with The Menarini Group, Deploying Medidata’s Study Build AI Technology to Accelerate Global Oncology Pipeline

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a strategic expansion of its partnership with The Menarini Group, a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc., a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments to cancer patients.

Press Release

March 9, 2026

Living Heart Project

A translational research initiative to revolutionize cardiovascular science through realistic simulation

Article

...